Zur Kurzanzeige

dc.creatorMessini C.I., Daponte A., Anifandis G., Mahmood T., Messinis I.E.en
dc.date.accessioned2023-01-31T08:59:17Z
dc.date.available2023-01-31T08:59:17Z
dc.date.issued2016
dc.identifier10.1016/j.ejogrb.2016.10.003
dc.identifier.issn03012115
dc.identifier.urihttp://hdl.handle.net/11615/76558
dc.description.abstractEvidence-based medicine is the principal approach to medical practice. There are several debatable issues in infertility, which require clarification. Over the past 20 years, reliable methodology has been developed for the management of infertile couples. This includes high quality diagnostic and therapeutic procedures, which are applied in highly specialised infertility centres. The European Board and College of Obstetrics and Gynaecology (EBCOG) has published Standards of Care for Women's Health in Europe, which should be the cornerstone for the clinicians and service providers in the European Union to establish common protocols within their centres. Each infertility treatment should result in the highest possible success rate and all appropriate measures for the patient's safety should be in place. The treatment protocols should minimise risk of complications, such as ovarian hyperstimulation syndrome (OHSS). The current use of GnRH agonists to trigger final follicle maturation has provided the means for avoiding this syndrome. Additionally, multiple pregnancy rates are still high in assisted reproductive technology (ART). These rates should be reduced by the adoption of single embryo transfer during IVF treatment and by the proper monitoring of ovulation induction protocols. EBCOG Standards of Care for infertility and assisted conception treatment derived from the best available evidence should underpin the provision of high quality infertility services in European countries. © 2016 Elsevier Ireland Ltden
dc.language.isoenen
dc.sourceEuropean Journal of Obstetrics and Gynecology and Reproductive Biologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85003712755&doi=10.1016%2fj.ejogrb.2016.10.003&partnerID=40&md5=d228f3c4464e4a94ce9d60affaadd6e4
dc.subjectandrogenen
dc.subjectantioxidanten
dc.subjectchorionic gonadotropinen
dc.subjectgonadorelin agonisten
dc.subjectgonadorelin antagonisten
dc.subjectluteinizing hormoneen
dc.subjectanovulationen
dc.subjectblastocysten
dc.subjectendometriosisen
dc.subjectendometrium polypen
dc.subjectEuropeen
dc.subjectevidence based medicineen
dc.subjectfemale infertilityen
dc.subjecthumanen
dc.subjecthydrosalpinxen
dc.subjectin vitro fertilizationen
dc.subjectinfertility therapyen
dc.subjectintrauterine inseminationen
dc.subjectluteal phaseen
dc.subjectovary follicle maturationen
dc.subjectovary hyperstimulationen
dc.subjectovulation inductionen
dc.subjectpriority journalen
dc.subjectReviewen
dc.subjectsingle embryo transferen
dc.subjectuterus myomaen
dc.subjectElsevier Ireland Ltden
dc.titleStandards of Care in infertility in Europeen
dc.typeotheren


Dateien zu dieser Ressource

DateienGrößeFormatAnzeige

Zu diesem Dokument gibt es keine Dateien.

Das Dokument erscheint in:

Zur Kurzanzeige